Mezzion Pharma Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
4,402
4,857
14,926
8,751
5,586
Cost of Goods Sold (COGS) incl. D&A
4,157
5,156
5,222
3,984
4,738
Gross Income
245
299
9,704
4,767
848
SG&A Expense
2,005
4,566
12,437
11,987
17,928
EBIT
2,473
4,865
2,733
7,220
17,121
Unusual Expense
-
63
7,317
3,771
3,573
Non Operating Income/Expense
57
59
798
682
92
Interest Expense
-
-
1,437
3,689
2,771
Pretax Income
518
3,331
5,161
12,808
15,629
Income Tax
312
763
939
176
747
Consolidated Net Income
831
2,568
4,223
12,985
14,882
Net Income
831
2,568
4,223
12,985
14,882
Net Income After Extraordinaries
831
2,568
4,223
12,985
14,882
Net Income Available to Common
831
2,568
4,223
12,985
14,882
EPS (Basic)
114.00
337.00
560.00
1,762.00
2,000.00
Basic Shares Outstanding
7
8
8
7
7
EPS (Diluted)
114.15
337.14
559.95
1,761.86
2,000.33
Diluted Shares Outstanding
7
8
8
7
7
EBITDA
2,424
4,714
2,390
6,805
17,058
Other Operating Expense
713
-
-
-
40
Non-Operating Interest Income
1,897
1,538
1,217
1,189
781
About Mezzion Pharma Co.
View Profile
